OncoFap vedotin

N/A

Report date: 2025/03/20 10:02:12
NME

Base Information

Drug NameOncoFap vedotin
Drug Alias Nameanti-FAP small molecule-drug conjugate (ETH Zurich/Swiss National Science Foundation/Philogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalySwitzerland
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSwiss Federal Institute Of Technology Zurich
China Registration ClassN/A

Develop Information

Active CompaniesSwiss Federal Institute Of Technology ZurichPhilogen SpaSwiss National Science Foundation
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A